Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

The ICON and AGO Collaborators

Research output: Contribution to journalArticlepeer-review

955 Citations (Scopus)
Original languageEnglish
Pages (from-to)2099-2106
Number of pages8
JournalThe Lancet
Volume361
Issue number9375
DOIs
Publication statusPublished - 21 Jun 2003

Cite this